Identifying enablers and barriers to individually tailored prescribing: a survey of healthcare professionals in the UK

被引:0
作者
Joanne Reeve
Nicky Britten
Richard Byng
Jo Fleming
Janet Heaton
Janet Krska
机构
[1] Hull University,Hull York Medical School
[2] University of Exeter Medical School,Warwick Primary Care, Warwick Medical School
[3] Clinical Trials and Health Research,Division of Health Research
[4] Peninsula Schools of Medicine and Dentistry,Medway School of Pharmacy
[5] ITTC,undefined
[6] Drake Circus,undefined
[7] University of Warwick,undefined
[8] University of the Highlands and Islands,undefined
[9] The Universities of Greenwich and Kent at Medway,undefined
来源
BMC Family Practice | / 19卷
关键词
Polypharmacy; Medicines optimisation; Individually tailored care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 34 条
  • [1] Stehlik J(2004)And an ARB makes nine: polypharmacy in patients with heart failure Cleve Clin J Med 71 674-676
  • [2] Taylor D(2006)Polypharmacy – appropriate and inappropriate Br J Gen Pract 56 484-485
  • [3] Aronson KR(2017)Validation of an instrument to measure patient experiences of medicines use: the living with medicines questionnaire (LMQ) Patient Prefer Adherence 11 671-279
  • [4] Krska J(2016)Rethinking how we understand individual health care needs for people living with long term conditions: a qualitative study Health and Soc Care Community 24 27-38
  • [5] Katusiime B(2011)Understanding patient experiences of treatment burden in chronic heart failure using normalisation process theory Ann Fam Med 9 235-243
  • [6] Corlett SA(2014)Thinking about the burden of treatment BMJ 349 g6680-517
  • [7] Reeve J(2007)2007. Inappropriate polypharmacy, reducing the burden of multiple medication Clin Med 7 514-194
  • [8] Cooper L(2006)Self-managing and managing self: practical and moral dilemmas in accounts of living with chronic illness Chronic Illn 2 185-1002
  • [9] Gallacher K(2009)Prioritizing illness: lessons in self-managing multiple chronic diseases Can J Sociol 34 983-320
  • [10] May CR(2015)Solutions to problematic polypharmacy: learning from the expertise of patients Br J Gen Pract 65 319-208